Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.44 USD
Change Today +0.02 / 0.58%
Volume 24.5K
ICAD On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 12:14 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

icad inc (ICAD) Key Developments

iCAD, Inc. Announces Commercial Availability of Cervical Applicator for Treatment of Gynecological Cancers

iCAD, Inc. announced the commercial availability of a new cervical applicator for the Xoft Axxent Electronic Brachytherapy System. The applicator and multi-platform controller will be showcased in the iCAD/Xoft booth (#1239) at the American Association of Physicists in Medicine (AAPM) annual meeting from July 12-16, 2015 in Anaheim, CA. Data from several studies involving use of surface HDR electronic brachytherapy is also being presented in multiple poster and oral presentations throughout the meeting. The cervical applicator, Xoft's first multi-channel applicator, is used to deliver a precise dose of radiation to larger target areas of the cervix while minimizing exposure to healthy tissue. The addition of the cervical applicator completes Xoft's gynecological product line, allowing radiation oncologists to treat all gynecological indications with the Xoft System.

iCAD Announces Launch of iReveal® Breast Density Analysis Solution as Latest Addition to PowerLook Advanced Mammography Platform

iCAD, Inc. announced the launch of the iReveal® breast density module as the latest addition to the Company's PowerLook Advanced Mammography Platform (AMP)®. The iReveal software is designed to deliver automated, rapid and reproducible assessments of breast density to help identify patients that may experience reduced sensitivity to digital mammography due to dense breast tissue. iReveal uses an advanced software program to assess breast density based on the range of categories established by the American College of Radiology's Breast Imaging Reporting and Data System (BI-RADS®), automating the same analytical approach used by many experienced radiologists. In many cases, patients with dense breast tissue may be recommended for additional screening exams including use of breast tomosynthesis.

iCAD, Inc. Withdraws 2015 Financial Guidance Due to General Reimbursement Uncertainty

iCAD, Inc. announced that it is withdrawing its full year 2015 financial guidance due to general uncertainty related to reimbursement for non-melanoma skin cancer in the United States. The company's guidance was based on the assumption that there would be no changes to the reimbursement environment for fiscal 2015. The company is proactively working to gain clarity on the issue and will provide an update on reimbursement when appropriate.

iCAD, Inc. Presents at 5th LD Micro Invitational Conference, Jun-02-2015 04:00 PM

iCAD, Inc. Presents at 5th LD Micro Invitational Conference, Jun-02-2015 04:00 PM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd, Los Angeles, CA 90049, United States.

iCAD Launches Digital Customer Training Platform to Support Professional Education in Use Of Xoft System for Treatment of Non-Melanoma Skin Cancer, Early-Stage Breast Cancer and Gynecological Cancers

iCAD, Inc. announced the launch of an enhanced eBx Institute including a new online learning and support platform for Xoft Electronic Brachytherapy (eBx) System users. eBx Institute will offer healthcare providers access to training modules and educational resources to support the treatment of non-melanoma skin cancer, early-stage breast cancer and gynecological cancers using the Xoft System. The web-based solution provides an array of on-demand, self-paced learning programs, including instructional courses and reference materials. eBx Institute will enable customers to: Self-enroll in training - Search for online course offerings - Manage course enrollments - View/print transcripts and training certificates upon course completion - Review supplemental training materials - Watch instructional procedure videos and online simulations. Xoft System users may consult the available information for a variety of different purposes including pre-requisite training, continuing education and post-ILT (instructor-led training) reference. The site also provides information to customers and addresses questions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICAD:US $3.44 USD +0.02

ICAD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elekta AB kr57.30 SEK -0.40
Hologic Inc $41.63 USD +0.88
Merge Healthcare Inc $5.49 USD -0.01
View Industry Companies
 

Industry Analysis

ICAD

Industry Average

Valuation ICAD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 0.9x
Price/Cash Flow 35.1x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICAD INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.